Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy

Neoplasia

Volumn 7, Issue 2, 2005, Pages 91-98

  Siu, Tim Cheung ^a,d   Ho, Jenny C Y ^a   Ka, Ling Leung ^a   Chen, Xin ^b   Fong, Daniel Y T ^a   So, Samuel ^c   Sheung, Tat Fan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AA454543; Gene expression; Liver cancer; Overall survival; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; DNA MICROARRAY; DNA TRANSCRIPTION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARTIAL HEPATECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

EID: 14644388800     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04472     Document Type: Article

References (37)

1. Pisani P, Parkin DM, Bray F, and Ferlay J (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83, 18-29.
2. Bruix J, Boix L, Sala M, and Llovet JM (2004). Focus on hepatocellular carcinoma. Cancer Cell 5, 215-219.
3. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, and Wong J (1999). Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229, 322-330.
4. Fong Y, Sun RL, Jarnagin W, and Blumgart LH (1999). An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229, 790-799.
5. Neuhaus P, Jonas S, and Bechstein WO (2000). Hepatoma of the liver - resection or transplantation? Langenbeck's Arch Surg 385, 171-178.
6. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, and Wong J (2001). Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234, 63-70.
7. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, Kimoto T, Takemoto Y, Nakamura T, and Yukaya H (1993). Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217, 375-384.
8. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, and Pigato P (1998). Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 82, 1028-1036.
9. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, and Brennan M (1995). Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169, 28-35.
10. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al. (2002). Gene expression patterns in human liver cancers. Mol Biol Cell 13, 1929-1939.
11. Simon R, Radmacher MD, Dobbin K, and McShane LM (2003). Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95, 14-18.
12. Sobin LH and Whitekind C (1997). TNM Classification of Malignant Tumours, 5th ed. Wiley, New York, USA.
13. Poon RT and Fan ST (2003). Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 12, 35-50.
14. Cheung ST, Chen X, Guan XY, Wong SY, Tal LS, Ng IO, So S, and Fan ST (2002). Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multi-nodular tumor. Cancer Res 62, 4711-4721.
15. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, Dwight SS, Kaloper M, Weng S, Jin H, Ball CA, et al. (2001). The Stanford Microarray Database. Nucleic Acids Res 29, 152-155.
16. Bustin SA (2000). Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25, 169-193.
17. Pepe MS, Janes H, Longton G, Leisenring W, and Newcomb P (2004). Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159, 882-890.
18. Youden WJ (1950). Index for rating diagnostic tests. Cancer 3, 32-35.
19. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al. (2001). Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nat Genet 29, 365-371.
20. Kawai HF, Kaneko S, Honda M, Shirota Y, and Kobayashi K (2001). Alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology 33, 676-691.
21. Lee J and Thorgeirsson SS (2002). Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 35, 1134-1143.
22. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, and Nakamura Y (2001). Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61, 2129-2137.
23. Shirota Y, Kaneko S, Honda M, Kawai HF, and Kobayashi K (2001). Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 33, 832-840.
24. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, et al. (2001). Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98, 15089-15094.
25. Neo SY, Leow CK, Vega VB, Long PM, Islam AF, Lai PB, Liu ET, and Ren EC (2004). Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 39, 944-953.
26. Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, et al. (2003). Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361, 923-929.
27. Ng IO, Lai EC, Fan ST, Ng MM, and So MK (1995). Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer 76, 2443-2448.
28. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL, and Wong J (2001). Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 19, 3037-3044.
29. Collins FS, Green ED, Guttmacher AE, and Guyer MS (2003). US National Human Genome Research. A vision for the future of genomics research. Nature 422, 835-847.
30. Mattick JS (2003). The human genome and the future of medicine. Med J Aust 179, 212-216.
31. Ayoubi P, Jin X, Leite S, Liu X, Martajaja J, Abduraham A, Wan Q, Yan W, Misawa E, and Prade RA (2002). PipeOnline 2.0: automated EST processing and functional data sorting. Nucleic Acids Res 30 4761-4769.
32. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
33. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW Lau C, Peterse JL, Roberts C, Marton MJ, et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347, 1999-2009.
34. Henshall SM, Afar DE, Hiller J, Horvath LG, Quinn DI, Rasiah KK, Gish K, Willhite D, Kench JG, Gardiner-Garden M, et al. (2003). Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Res 63, 4196-4203.
35. Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, et al. (2002). Combined use of oligonucteotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res 62, 3971-3979.
36. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al. (2002). Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8, 816-824.
37. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, et al. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436-442.